"I love UsAgainstAlzheimer’s"

2022-07-04 06:13:33

Skip to main content .st0{fill:#0047BA;} .st1{fill:#CF0A2C;} .st0{fill:#0047BA;}.st1{fill:#CF0A2C;} Sign Up Donate Main navigation About Us Our Impact Our Team Our Board Careers Contact Alzheimer's is the 6th leading cause of death in the United States, and the only top-10 deadly disease not to have a treatment or cure. About UsA2 Watch the Video Connect with Us Like Us on Facebook Follow Us on Twitter Follow us in YouTube Get Email Updates Our Work Programs Finding effective treatments and the prevention steps to stop Alzheimer’s Read More Networks & Coalitions Engaging and activating diverse communities most deeply affected by Alzheimer’s Read More Convened Consortiums Convening a range of key stakeholders to take action on big issues. Read More Incubated Initiatives Spurring social innovation through transformative initiatives. Read More News & Media Press Releases Blog Videos Press Kit Podcasts May 9, 2022 UsAgainstAlzheimer's A-LIST Pulse of the Community Vol 11, May 2022 The mission of the A-LIST is to use survey results to make... Read more Join Us Join UsAgainstAlzheimer's right now to make a difference in the fight to stop Alzheimer's. Join Connect with Us Like Us on Facebook Follow Us on Twitter Follow us in YouTube Get Email Updates Research & Insights The Crisis: Key Facts Brain Health Early Detection Disparities Clinical Trials Reports & Research A-LIST Pulse of the Community - December 2021 Download Report Get Involved Advocate Ways to Give Corporate Partnerships and Sponsorship UsA2 Events Activist Toolkit National Summit CHANGE Act EVENT National Alzheimer’s SummitThank you to all who made this Summit successful! Learn More POLICY RESOURCESRESOURCESStay updated on UsA2 legislative requests and policy.Read More Menu Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s The fight to end Alzheimer’s got a major boost today as the U.S. House Appropriations Committee passed significant funding increases for Alzheimer’s research, prevention, and treatment. Read More New Data Shows Hope for Reducing Agitation in Alzheimer’s Patients UsAgainstAlzheimer’s hailed the release of a new data indicating a drug may help patients living with Alzheimer’s-related agitation. In addition to the impact agitation has on patients, it is also one of the most stressful challenges facing their caregivers. Learn More The Brain Health Academy Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s. Learn more Say Hello to BrainGuide Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease. Learn More New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials. Learn More Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s Alzheimer’s-related agitation is one of the most difficult challenges facing patients and caregiver The Brain Health Academy Say Hello to BrainGuide Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments UsAgainstAlzheimer's: Working to End Alzheimer's Disease The Alzheimer’s pandemic is one of the most significanthealth and social economic crisesof this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.We bring all of “Us” together to:Improve brain health and promote earlier detection, diagnosis and interventionChampion health equity and access for communities of color and women who are disproportionately impacted by the diseaseAdvocate for increased research spending that will speed treatments to marketDrive changes that matter most to people living with the disease and caregiversIn the past decade, progress has been made, with more hope on the horizon now than ever before.But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now. Recent News and Blog Posts All Content Types Blog Article News Press Release June 30, 2022 Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s Washington, D.C. – The fight to end Alzheimer’s got a major boost... Read more June 28, 2022 New Data Shows Hope for Reducing Agitation in Alzheimer’s Patients Washington, D.C. – Today, UsAgainstAlzheimer’s hailed the release of a new data... Read more June 23, 2022 UsAgainstAlzheimer’s Statement on Passage of the Advanced Research Projects Agency for Health (ARPA-H) Act (H.R. 5585) Washington, DC (June 22, 2022)— Today, UsAgainstAlzheimer’s issued the following statement... Read more June 23, 2022 Read Full Article Caregiver appraisals of lucid episodes in people with late-stage Alzheimer's disease or related dementias Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, June 2022 Read more June 17, 2022 UsAgainstAlzheimer’s Board Member Testifies on Alzheimer’s-Related Psychosis Before FDA Advisory Committee Washington, DC (June 17, 2022)— Today, UsAgainstAlzheimer’s Board Member Meryl Comer... Read more June 17, 2022 UsAgainstAlzheimer’s Statement on Crenezumab Trial Results Washington, DC (June 16, 2022) — Today, UsAgainstAlzheimer’s Chair and co-founder George... Read more Reports Resources December 20, 2021 A-LIST Pulse of the Community - December 2021 Read More (1.47 MB) Resources July 23, 2021 2020 Annual Report In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2020.  Read More (7.13 MB) Resources November 14, 2020 Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that... Read More (3.37 MB) × Footer menu Annual Report Financials Privacy Policy Terms & Conditions © UsAgainstAlzheimer's 2022 .st0{fill:#0047BA;} .st1{fill:#CF0A2C;} .st0{fill:#0047BA;}.st1{fill:#CF0A2C;}